Press Releases

igc pharma
IGC Nominates Mr. John E. Lynch to Its Board of Directors
Read More →
igc pharma
IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients
Read More →
igc-ad1 igc pharma
IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer’s Patients
Read More →
igc-ad1
IGC Reports Financial Results for June 30, 2020 Quarter and Prepares for Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients
Read More →
clincloud
FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s
Read More →
artificial intelligence igc pharma
IGC Filed a Patent for a New Formulation to Treat Pain
Read More →
healthcare summit tgr-63 biotech igc pharma
IGC Receives a Notice of Allowance from the U.S. Patent Office
Read More →
igc pharma
IGC Reports Financial Results for Fiscal Year Ended March 31 2020
Read More →
igc pharma
Update to Notice to Investors
Read More →
igc pharma
IGC Announces Proposed Settlement of 3 Derivative Lawsuits & Provides Notice to Shareholders
Read More →